Sugar-Based gel shows promise for stroke patients in early trial
NCT ID NCT06700824
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tested a new gel called OTR4132 in 60 people who had a stroke and received a clot-removal procedure. The gel is designed to help repair damaged brain tissue. Researchers measured neurological function at 24 hours and disability at 3 months to see if the gel improves recovery compared to a placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
OTR4132 (a sugar-based gel that helps repair damaged tissue)
What this could lead to
If it works, this could point toward a new treatment to help people recover better after a stroke.
What could go wrong
This is a small, early-phase trial with only 60 people, so results may not apply to everyone. The treatment is still experimental and may not show clear benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- THUNDER Stroke Study: Penumbra System with Thund NCT05437055
- Stroke Alarm Efficacy Trial (NCT06315192)
- IMPROVE-II: FAST Model for Stroke Reperfusion (NCT06330051)
- Virtual Reality Rehab for Stroke Recovery - NCT07674329
- Endovascular Therapy for Basilar Artery Stroke (NCT07672795)
- Oropharyngeal Suction Tube for Stroke Pneumonia NCT07647666
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Henri-Mondor
Créteil, 94000, France
-
Centre Hospitalier Régional Universitaire de Lille- Hôpital Roger Salengro
Lille, 59000, France
-
Centre Hospitalier Régional Universitaire de Nancy
Nancy, 54000, France
-
Centre Hospitalier Universi-taire de Bordeaux-Hôpital Pellegrin
Bordeaux, 33076, France
-
Centre Hospitalier Universitaire Grenoble Alpes
Grenoble, 38043, France
-
Centre Hospitalier Universitaire de Martinique
Fort de France, 97261, France
-
Centre Hospitalier Universitaire de la Guadeloupe
Pointe à Pitre, 97159, France
-
Centre hospitalier universi-taire de Brest (Cavale Blanche)
Brest, 29609, France
-
GHU Paris Psychiatrie & Neurosciences
Paris, France, France
-
Hôpital Foch
Suresnes, 92150, France
-
Hôpital Fondation Adolphe de Rothschild Service de neuro-vasculaire
Paris, 75019, France
-
Hôpital de Hautepierre
Strasbourg, 67200, France
-
Hôpital de la Pitié Salpêtrière - AP-HP
Paris, 75013, France
-
Hôpitaux Universitaires De Marseille Timone-AP-HM
Marseille, 13385, France
-
UIC Imagerie et Neurovasculaire CHU de Nantes
Nantes, 44093, France